Iron-acrylic compound for stereotaxic aneurysm thrombosis

Abstract
A new iron-acrylic compound was developed for stereotaxic thrombosis of intracranial aneurysms. The compound polymerizes rapidly, does not fragment and is nontoxic. It was used in a series of experimental animals (dog) and initial clinical cases (human) with good results. The use of this material simplifies and increases the safety of stereotaxic aneurysm treatment.
Keywords

This publication has 6 references indexed in Scilit: